Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Janssen

Showing results (111-120 of 1,929) with videos related to

Pageof 193
Sort By:
Gastroenterology|May 22, 2022
ReplyGrishma Hirode, Harry L A Janssen
Biochemical Pharmacology|April 15, 1979
alpha-Ketoaldehydes, specific catalysts for thiol formation from levamisoleH Van Belle, P A Janssen
Arzneimittel-Forschung|January 1, 1974
Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidolC J Niemegeers, P A Janssen
Gastroenterology|June 1, 2014
Averting hepatocellular carcinoma in chronic hepatitis B with antiviral therapy: tipping the balance or not yet?Harry L A Janssen, Ambreen Arif
Plos One|July 27, 2016
Stimulating Contributions to Public Goods through Information Feedback: Some Experimental ResultsMarco A Janssen, Allen Lee, Hari Sundaram
Alimentary Pharmacology & Therapeutics|February 13, 2019
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' replyKin Seng Liem, Harry L A Janssen
Thorax|October 31, 2019
Palliative treatment of chronic breathlessness syndrome: the need for P5 medicineDaisy J A Janssen, Miriam J Johnson
Journal of Hepatology|December 15, 2025
Individualizing endpoints in chronic HBV treatment: HBsAg loss and beyondMilan J Sonneveld, Harry L A Janssen
Clinics in Chest Medicine|May 31, 2014
Palliative care and pulmonary rehabilitationDaisy J A Janssen, James R McCormick
Arzneimittel-Forschung|March 1, 1972
Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 3. Inhibition of the peristaltic activity of the guinea pig ileum in vitroJ M van Nueten, P A Janssen
Pageof 193

Showing results (111-120 of 1,929) with videos related to

Sort By:
Pageof 193
Gastroenterology|May 22, 2022
ReplyGrishma Hirode, Harry L A Janssen
Biochemical Pharmacology|April 15, 1979
alpha-Ketoaldehydes, specific catalysts for thiol formation from levamisoleH Van Belle, P A Janssen
Arzneimittel-Forschung|January 1, 1974
Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidolC J Niemegeers, P A Janssen
Gastroenterology|June 1, 2014
Averting hepatocellular carcinoma in chronic hepatitis B with antiviral therapy: tipping the balance or not yet?Harry L A Janssen, Ambreen Arif
Plos One|July 27, 2016
Stimulating Contributions to Public Goods through Information Feedback: Some Experimental ResultsMarco A Janssen, Allen Lee, Hari Sundaram
Alimentary Pharmacology & Therapeutics|February 13, 2019
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' replyKin Seng Liem, Harry L A Janssen
Thorax|October 31, 2019
Palliative treatment of chronic breathlessness syndrome: the need for P5 medicineDaisy J A Janssen, Miriam J Johnson
Journal of Hepatology|December 15, 2025
Individualizing endpoints in chronic HBV treatment: HBsAg loss and beyondMilan J Sonneveld, Harry L A Janssen
Clinics in Chest Medicine|May 31, 2014
Palliative care and pulmonary rehabilitationDaisy J A Janssen, James R McCormick
Arzneimittel-Forschung|March 1, 1972
Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 3. Inhibition of the peristaltic activity of the guinea pig ileum in vitroJ M van Nueten, P A Janssen
Pageof 193